V2X, Inc.
No SEC Form 4 filings for $VVX in the last 30 days.
BlackRock, Inc. filed an amended Schedule 13G for V2X, INC. reporting beneficial ownership of 3,840,078 shares, about 12.3% of V2X’s outstanding common stock. The filing states sole voting power for 3,796,156 shares and sole dispositive power for all 3,840,078 shares, with no shared power reported.
Analysts cited bullish views on industrial and technology stocks. BTIG reiterated a Buy on V2X (VVX) with a $90 target versus a $78.76 close, and TipRanks consensus targets $89.30. Clear Street reiterated a Buy on Red Cat Holdings (RCAT) with a $19 target versus $8.86 close. Stifel reiterated Buy on Latham Group (SWIM) with a $9.50 target versus $5.70 close.
Simply Wall St reports V2X (NYSE:VVX) shares fell nearly 9% after its Q2 results. The company posted Q2 revenue of about $1.26b (+16.5%), net income $25.5m (+14.1%), and basic EPS $0.82 (+15.4%). It also raised full-year guidance for revenue, adjusted EBITDA and EPS, while investors questioned valuation.
Over the past 7 days, alphai's AI scored 6 news stories mentioning VVX (V2X, Inc.). Coverage has been balanced: 1 bullish, 4 neutral, and 1 bearish.
Recent VVX coverage spans financial news, market movers and earnings.
The filing is a new, disclosed ownership stake that can affect positioning, liquidity expectations, and near-term sentiment around V2X.
Analyst reiteration with a specific $90 target and a prior close provides a near-term sentiment and valuation reference point.
Raised guidance and improved cash generation are being discounted due to valuation and concerns about lumpy bookings and concentration risk.
The contract is a fundamental positive, but the immediate selloff suggests traders are discounting margin, timing, or competitive/implementation risk.
Guidance implies a sharp Kuwait slowdown but steadier national security support, shifting the revenue mix and near-term margin outlook.
alphai scores every news story that mentions VVX with an AI model for sentiment and relevance, and aggregates insider trades from V2X, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
BlackRock, Inc. filed an amended Schedule 13G for V2X, INC. reporting beneficial ownership of 3,840,078 shares, about 12.3% of V2X’s outstanding common stock. The filing states sole voting power for 3,796,156 shares and sole dispositive power for all 3,840,078 shares, with no shared power reported.
2 min readAnalysts cited bullish views on industrial and technology stocks. BTIG reiterated a Buy on V2X (VVX) with a $90 target versus a $78.76 close, and TipRanks consensus targets $89.30. Clear Street reiterated a Buy on Red Cat Holdings (RCAT) with a $19 target versus $8.86 close. Stifel reiterated Buy on Latham Group (SWIM) with a $9.50 target versus $5.70 close.
3 min readSimply Wall St reports V2X (NYSE:VVX) shares fell nearly 9% after its Q2 results. The company posted Q2 revenue of about $1.26b (+16.5%), net income $25.5m (+14.1%), and basic EPS $0.82 (+15.4%). It also raised full-year guidance for revenue, adjusted EBITDA and EPS, while investors questioned valuation.
6 min readV2X, Inc. (VVX) shares fell about 12% after the U.S. Air Force awarded the company an indefinite-delivery/indefinite-quantity contract for Contractor Logistics Support for the C-12 aircraft fleet. The contract has a $500 million ceiling value, according to the company. The stock was around $76.12, down from $86.38 at the prior close.
1 min readV2X (NYSE:VVX) reported Q2 earnings call highlights. CFO Shawn Mural said Kuwait activity is expected to drop in H2, with Kuwait revenue of about $20M to $30M versus ~$180M in H1. National security support revenue is expected around $180M in H2. Bookings were $600M, backlog $12.7B, and adjusted operating cash flow was $71.8M.
6 min readV2X, Inc. (VVX) filed an SEC Form 8-K — Results of Operations and Financial Condition. vec-20260803 false 0001601548 0001601548 2026-08-03 2026-08-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported):
6 min readS&P Dow Jones Indices said Krystal Biotech (KRYS) will move from the S&P SmallCap 600 to the S&P MidCap 400, replacing Taylor Morrison Home (TMHC). Tutor Perini (TPC) will replace Krystal Biotech in the SmallCap 600. Berkshire Hathaway (BRK.A/BRK.B) is acquiring Taylor Morrison. V2X (VVX) will replace Avanos Medical (AVNS) in the SmallCap 600 as American Industrial Partners’ acquisition is expected to close soon.
2 min readInvesting.com reports Tutor Perini (NYSE:TPC) rose 7.4% after hours and V2X (NYSE:VVX) gained 3.9% after S&P Dow Jones Indices said both will be added to the S&P SmallCap 600. TPC replaces Krystal Biotech (NASDAQ:KRYS) effective July 24. VVX joins July 27 replacing Avanos Medical (NYSE:AVNS), which is being acquired by American Industrial Partners.
3 min readWall Street analyst calls for June 24, 2026 covered upgrades, downgrades, and initiations across sectors. Wells Fargo upgraded Invitation Homes to Overweight, lifting its target to $33. Citigroup raised Macerich to Buy ($28). KeyBanc increased Nucor to Overweight ($274). Downgrades included Flowserve to Hold ($70) at TD Cowen and Nuvalent to Market Perform ($124) from Bernstein.
4 min readV2X, Inc. director Gerard A. Fasano reported equity compensation activity on May 7, 2026, where he exercised 838 restricted stock units (RSUs) and received a new award of 2,188 RSUs. These new RSUs are scheduled to vest by May 7, 2027, or earlier, at the company's 2027 Annual Shareholders' Meeting. This activity resulted in Fasano directly holding 838 shares of V2X common stock and having 2,188 RSUs outstanding.
2 min read
